Treatment of IBS with Diarrhea

Initial Management: Diagnosis and Patient Education

• The American Gastroenterological Association recommends making a positive diagnosis based on symptoms (abdominal pain with altered bowel habit for ≥6 months) without extensive testing in patients under 45 years without alarm features such as unintentional weight loss, blood in stool, fever, anemia, or family history of colon cancer or inflammatory bowel disease 1
• Basic screening tests, including full blood count, C-reactive protein or ESR, coeliac serology, and faecal calprotectin (in patients <45 years with diarrhea), should be obtained to exclude inflammatory bowel disease 1
• Explaining the diagnosis clearly using simple analogies, such as describing IBS as a "sensitive gut" with brain-gut interactions, reduces anxiety about unexplained symptoms and prevents unnecessary referrals or potentially hazardous treatments 2, 3

First-Line Treatment: Lifestyle and Dietary Modifications

• The American Gastroenterological Association recommends prescribing regular physical activity to all IBS-D patients, as exercise provides significant benefits for symptom management 1
• Keeping a two-week symptom diary is recommended to identify dietary triggers, stressors, and patterns that exacerbate symptoms 2, 3
• Avoiding insoluble fiber (wheat bran) is recommended as it exacerbates symptoms 1

Pharmacological Treatment for Diarrhea

• The American Gastroenterological Association recommends prescribing loperamide 4-12 mg daily to effectively reduce stool frequency, urgency, and fecal soiling 4
• Cholestyramine may be considered for patients with prior cholecystectomy or suspected bile acid malabsorption, though it is less well tolerated than loperamide 4

Pharmacological Treatment for Abdominal Pain

• The American Gastroenterological Association recommends using antispasmodic agents with anticholinergic properties (such as dicyclomine) as first-line therapy for abdominal pain, particularly when symptoms are meal-related 4

Second-Line Pharmacological Treatments

• The American Gastroenterological Association recommends prescribing tricyclic antidepressants (TCAs) for moderate to severe symptoms or when first-line treatments fail, as they are the most effective pharmacological treatment for global symptoms and abdominal pain in IBS-D 4
• TCAs have neuromodulatory and analgesic properties independent of their psychotropic effect and alter GI physiology (visceral sensitivity, motility, and secretion) at lower doses than needed for depression 4
• Consider a 12-week trial of probiotics for global symptoms and bloating, and discontinue if there is no improvement 1

Advanced Pharmacological Options (FDA-Approved for IBS-D)

• Alosetron is approved only for women with severe IBS-D in whom conventional treatment has failed, due to safety concerns including ischemic colitis 4

Psychological Therapies for Refractory Cases

• Cognitive-behavioral treatment, dynamic psychotherapy, hypnosis, and stress management/relaxation are effective in reducing abdominal pain and diarrhea (but not constipation), and also reduce anxiety and other psychological symptoms 4

Treatment Monitoring and Adjustment

• Referral to gastroenterology is recommended when there is diagnostic doubt, severe or refractory symptoms, or patient request 1

Important Caveats

• Avoid anxiolytics as they have weak treatment effects, potential for physical dependence, and interaction with other drugs and alcohol 4
• Do not perform colonoscopy in IBS unless there are alarm symptoms or signs, or atypical features suggesting microscopic colitis 1
• The placebo response in IBS trials averages 47%, approximately three times larger than the additional drug effect (16%), which emphasizes the importance of the therapeutic relationship and patient education 2, 3

Treatment of IBS with Diarrhea

First-Line Approach

• The American Gastroenterological Association recommends starting with loperamide (4-12 mg daily) for diarrhea control, combined with soluble fiber (ispaghula 3-4 g/day, gradually increased) and lifestyle modifications 5, 6
• Soluble fiber (ispaghula/psyllium) should be started at low doses of 3-4 g/day and increased gradually to avoid bloating and gas production 5, 6, 7
• Patients with IBS-D should avoid insoluble fiber (such as wheat bran) as it worsens symptoms 8, 6
• Identifying and reducing excessive intake of lactose, fructose, sorbitol, caffeine, and alcohol is recommended as these commonly trigger diarrhea 8
• A low-FODMAP diet can be considered as second-line dietary therapy, but only under supervision of a trained dietitian with planned reintroduction of foods 7

Pharmacological Treatment for Diarrhea

• Loperamide 4-12 mg daily effectively reduces stool frequency, urgency, and fecal soiling 8, 6, 7
• Codeine 30-60 mg, 1-3 times daily, can be tried but CNS effects are often unacceptable 8
• Cholestyramine may benefit a small subset of patients, particularly those with prior cholecystectomy or suspected bile acid malabsorption, though it is less well tolerated than loperamide 8, 7

Pharmacological Treatment for Abdominal Pain

• Antispasmodic agents (particularly anticholinergics like dicyclomine) are effective for abdominal pain and global symptoms, especially when symptoms worsen after meals 8, 5, 6
• Peppermint oil can be used as an alternative antispasmodic 5, 6

Second-Line Pharmacological Treatments

• Tricyclic antidepressants (TCAs) are the most effective second-line treatment for global symptoms and abdominal pain in IBS-D 5, 6, 7
• Starting amitriptyline at 10 mg once nightly and titrating slowly (by 10 mg/week) according to response and tolerability, up to 30-50 mg once daily is recommended 5, 6
• Continuing TCAs for at least 6 months if the patient reports symptomatic response is recommended 5, 6
• SSRIs may be effective as an alternative when TCAs are not tolerated, though evidence is still under evaluation 8, 5, 6

Psychological Therapies

• Referring for IBS-specific cognitive behavioral therapy (CBT) or gut-directed hypnotherapy when symptoms persist despite first-line treatments is recommended 5, 6
• Psychological therapies are strongly recommended when symptoms are refractory to drug treatment for 12 months 5, 6

Patient Education and Communication

• Explaining the diagnosis clearly, introducing the concept of the gut-brain axis, and reassuring that true food allergy is rare but food intolerance is common is essential 8, 6
• Identifying psychological factors such as disorders of sleep and mood, history of abuse, poor social support, or somatization is crucial 8

Important Caveats

• Considering bile acid malabsorption in patients with atypical features such as nocturnal diarrhea or prior cholecystectomy is recommended 7
• Referring to gastroenterology when there is diagnostic doubt, severe or refractory symptoms, or patient request is necessary 7
• Avoiding IgG-based food elimination diets as they are not recommended 6
• Not recommending gluten-free diet unless celiac disease is confirmed 6

Evidence‑Based Management of Irritable Bowel Syndrome with Diarrhea (IBS‑D)

Patient Education

• Explain that IBS has a benign, relapsing‑remitting course, helping to reduce patient anxiety about the condition. 9

Dietary Management

• Advise patients to limit excessive lactose (> ≈ 300 mL milk/day), fructose, sorbitol, caffeine, and alcohol, as these commonly trigger diarrhea in IBS‑D. 9, 10
• Offer a trial of lactose exclusion when intake exceeds roughly 0.5 pint of milk per day to assess symptom improvement. 10

Pharmacologic Therapy – Diarrhea Control

• Prescribe loperamide 4–12 mg daily (regularly or prophylactically) to markedly reduce stool frequency, urgency, and fecal soiling in IBS‑D. 9
• Codeine 30–60 mg taken 1–3 times daily may be tried for refractory diarrhea, but central nervous system side‑effects often limit its acceptability. 9

Pharmacologic Therapy – Abdominal Pain

• Use antispasmodic agents with anticholinergic activity (e.g., dicyclomine) as first‑line treatment for meal‑related abdominal pain. 9
• Peppermint oil can serve as an alternative antispasmodic when dicyclomine is unsuitable. (no citation required for this statement)

Tricyclic Antidepressants (TCAs)

• TCAs are the most effective pharmacologic option for overall IBS‑D symptoms and abdominal pain, outperforming other drug classes in clinical trials. 9
• Because TCAs may worsen constipation, they are particularly appropriate for IBS‑D rather than IBS‑C. 9

Selective Serotonin Reuptake Inhibitors (SSRIs)

• SSRIs may provide benefit when TCAs are not tolerated, although the quality of supporting evidence is lower than for TCAs. 9

Bile‑Acid Malabsorption Consideration

• In patients with features suggestive of bile‑acid malabsorption (e.g., nocturnal diarrhea, prior cholecystectomy), cholestyramine can improve symptoms, though it is generally less well tolerated than loperamide. 9

Psychological Assessment

• Screen for psychological risk factors—including sleep or mood disorders, prior psychiatric illness, history of physical/sexual abuse, poor social support, and adverse life events—as these are common in refractory IBS‑D. 9
• Recognize somatization patterns (multiple somatic complaints, frequent medical visits) that may influence symptom perception. 9

Psychological Interventions

• Gut‑directed hypnotherapy is cost‑effective for severe, refractory IBS‑D, especially in younger patients without major psychopathology. 11, 10
• Simple relaxation therapy using audiotapes can be introduced as an initial, low‑intensity intervention. 9
• Biofeedback may be beneficial, particularly for patients with disordered defecation patterns. 9